Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier

Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier

Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier

Posted: 29 Nov 2020 09:58 AM PST

"

Up-To-Date research on Human Papillomavirus (HPV) Vaccines Market 2020-2025 :

The Reputed Garner Insights website offers vast reports on different market.They cover all industry and these reports are very precise and reliable. It also offers Human Papillomavirus (HPV) Vaccines Market Report 2020 in its research report store. It is the most comprehensive report available on this market. The report study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Human Papillomavirus (HPV) Vaccines Market.

The study gives a transparent view on the Global Human Papillomavirus (HPV) Vaccines Market and includes a thorough competitive scenario and portfolio of the key players functioning in it. To get a clear idea of the competitive landscape in the market, the report conducts an analysis of Porter's Five Forces Model. The report also provides a market attractiveness analysis, in which the segments and sub-segments are benchmarked on the basis of their market size, growth rate, and general attractiveness.

Request Sample Report of Global Human Papillomavirus (HPV) Vaccines Market https://garnerinsights.com/COVID-19-Version-Global-Human-Papillomavirus-HPV-Vaccines-Market-Status-2015-2019-and-Forecast-2020-2025-by-Region-Product-Type–End-Use#request-sample 

Key Players Types Application
, Merck, GSK, Walvax, , 2-Valent Vaccine, 4-Valent Vaccine, , Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others,

Some of the major geographies included in the market are given below:
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy)
Asia Pacific (China, India, Japan, Singapore, Malaysia)
Latin America (Brazil, Mexico)
Middle East & Africa

Ask For Instant Discount @ https://garnerinsights.com/COVID-19-Version-Global-Human-Papillomavirus-HPV-Vaccines-Market-Status-2015-2019-and-Forecast-2020-2025-by-Region-Product-Type–End-Use#discount

Components of the Human Papillomavirus (HPV) Vaccines Market report:
-A detailed assessment of all opportunities and risk in this Market.
-Recent innovations and major events
-A comprehensive study of business strategies for the growth of the Human Papillomavirus (HPV) Vaccines leading market players.
-Conclusive study about the growth plot of Human Papillomavirus (HPV) Vaccines Market for the upcoming years.
-Understanding of Human Papillomavirus (HPV) Vaccines Industry-particular drivers, constraints and major micro markets in detail.
-An evident impression of vital technological and latest market trends striking the Market.

The objectives of the study are as follows:

  • To identify, determine, and forecast the Global Human Papillomavirus (HPV) Vaccines Market segments based on its type, sub-type, technology used, applications, end-users, and regions.
  • To examine the micro markets based on individuals growth trends, development patterns, future prospects, and contribution to the overall market.
  • To study the opportunities in the market for different stakeholders and investors by determining the high-end growth segments and sub-segments.
  • To determine the size of the overall market, in terms of value, and for various segments with regards to North America, Asia-Pacific, Latin America, and the Middle East and Africa.
  • To accurately profile key vendors and players functioning in the market, in terms of their ranking and core competencies, together with determining the competitive landscape.
  • To study competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Human Papillomavirus (HPV) Vaccines Market.

View Full Report @ https://garnerinsights.com/COVID-19-Version-Global-Human-Papillomavirus-HPV-Vaccines-Market-Status-2015-2019-and-Forecast-2020-2025-by-Region-Product-Type–End-Use

Contact Us
Kevin Thomas
Email: sales@garnerinsights.com
Contact No:
+1 513 549 5911 (US)  |  +44 203 318 2846 (UK)"

Study aims to reduce HPV and COVID-19 vaccine hesitancy among teens in rural Alabama - The Mix

Posted: 11 Nov 2020 12:00 AM PST

Investigators are developing a telemedicine program to reduce vaccine hesitancy related to HPV and the novel coronavirus for adolescents in rural Alabama.

Editor's Note: The information published in this story is accurate at the time of publication. Always refer to uab.edu/uabunited for UAB's current guidelines and recommendations relating to COVID-19.

Henna Budhwani, Ph.D., a medical sociologist and an assistant professor at the UAB School of Public HealthHenna Budhwani, Ph.D., a medical sociologist and an assistant professor at the UAB School of Public Health and Tina Simpson, M.D., a pediatrician at UAB, are the co-principal investigators of the studyNationally, nearly half of adolescents are up to date on their human papillomavirus vaccines. However, in Alabama, only 20 percent of adolescents have received all doses of this vaccine. Moreover, in some of the state's rural counties, HPV vaccination rates are as low as 9 percent.  

Identifying ways to encourage adolescents in rural communities to learn about and accept FDA-approved vaccines is the focus of a new study led by a researcher at the University of Alabama at Birmingham.

Henna Budhwani, Ph.D., a medical sociologist and an assistant professor at the UAB School of Public Health, has received a $300,000 grant from Merck, Sharp and Dohme, Corp. The money will be used to develop and test the feasibility and acceptability of a telemedicine (mHealth) intervention, to reduce vaccine hesitancy by increasing vaccine education and promote teens' autonomy for their own health.

"Reducing vaccine hesitancy in the rural Deep South is a high-priority public health target," Budhwani said. "Focusing on increasing HPV vaccine awareness and understanding the causes of COVID-19 vaccine hesitancy are urgently warranted, due to low rates of HPV vaccine that lead to high rates of preventable cancers, and high rates of COVID-19 that disproportionately affect African American populations."

Budhwani and Tina Simpson, M.D., the study's co-principal investigator and a professor in the Department of Pediatrics at UAB, are creating this mHealth intervention. 

"Adolescents in these rural communities are clinically underserved, and their parents may not know about the HPV vaccine or their child's risk for developing cervical or oropharyngeal cancers," Budhwani explained. "The few providers that work in rural communities are often so overburdened providing first-line care that they may not even offer the HPV vaccine."

As part of this project, Budhwani and Simpson will conduct interviews with adolescents and their parents to better understand vaccine hesitancy related to COVID-19; this will enable Budhwani and Simpson to prepare high-impact messaging to spread information about the novel coronavirus vaccine when it becomes available.

"African American communities are disproportionately affected by COVID-19, and the same reasons underlying vaccine hesitancy related to the HPV vaccine have the potential to negatively influence the acceptance, uptake and confidence in a new novel coronavirus vaccine," Budhwani said. "We anticipate that, through our study, we will improve participants' knowledge of HPV and COVID-19, increase their understanding of the importance of vaccinations, and reduce stigmas associated with vaccination, COVID-19, HPV and cervical cancer."

The study will begin in early 2021.

A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region. - Physician's Weekly

Posted: 29 Nov 2020 09:18 PM PST

Human papillomavirus (HPV) is a major cause of cervical cancer in women. The characteristics of HPV infection vary; therefore, it is necessary to identify the most common HPV genotypes among a group of subjects when introducing a vaccine program. Currently, in the Yanbian Autonomous Region, no HPV vaccinations are not provided, and no data has been reported regarding HPV rates or genotype prevalence. We aimed to find the most suitable HPV vaccine for this region and reasons why no vaccine has been introduced.
HPV genotyping of 200 Korean-Chinese women living in the Yanbian Autonomous Region who visited the hospital for annual health examination was done. We also checked main factors necessary for HPV vaccine administrative system; (1) vaccine manufacturers in China, (2) vaccine importers, (3) vaccine suppliers, (4) applicable vaccine laws, (5) the HPV vaccine permit system in Jilin Province, and (6) vaccination hospital facilities-were assessed by direct inquiry and search.
The results showed that HPV genotypes 52, 58, 16, 53, and 33 were the most common among Korean-Chinese women. These results differed from those previously reported for Korean or Chinese women. All elements necessary for introduction of HPV vaccine were prepared, but there is no HPV vaccination plan based on epidemiological investigation.
Gardasil® 9 should be the most suitable vaccine for Korean-Chinese women with HPV infection and cervical cancer in this region considering the prevalence of certain genotypes. Governments and medical institutions should take an active stance on HPV vaccination to lower the incidence of cervical cancer here. Our study may serve as an important reference for introducing a Chinese government program designed to prevent cervical cancer.

References

PubMed

Comments

Post a Comment

Popular posts from this blog

Effect of a board game on imprisoned women's knowledge about ... - BMC Public Health

Image
The Previna board game was designed to be a complementary tool in the teaching and learning process about STIs for imprisoned women. The results showed that this educational technology significantly increased the players' knowledge about STIs and that this increase in knowledge remained significant during follow-up. This suggests that there was knowledge retention in the period researched. The increase in knowledge was also present in other studies that used board games for educational purposes [13,14,15,16]. The knowledge retention observed in this study is a result that draws attention, as the school teachers frequently mentioned that the women had difficulty retaining the contents taught in the classroom. This suggests that the approach to content may or may not favor this process. In this way, the board game can be used to present educational content to adult students in order to address their learning needs [14] and to make learning more significant and engaging. Regardless of...
Read more

Herpes Simplex: Two Types, Comparison Chart, Prevention - Verywell Health

Image
Herpes is a viral infection transmitted through skin contact. The two most common strains, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), cause oral herpes (cold sores) and genital herpes infections. Between 50% and 80% of people in the United States have HSV-1, and almost 12% of people between the ages of 14 and 49 have an HSV-2 infection. Read on for more information on both herpes simplex viruses, including transmission, symptoms, diagnosis, and treatment. belchonock / Getty Images Types of Herpes Simplex There are two types of HSV strains: HSV-1 : This strain typically causes an oral herpes infection but can cause symptoms in the genital area if that is where the virus was transmitted. HSV-2 : This virus strain typically causes symptoms in the genital and anal area. It may also cause an infection in or around the mouth. While each strain does commonly cause an infection on a particular part of the body, it is possible fo...
Read more

The 5 Best OTC Cold Sore Treatments of 2024 - Health.com

Image
Cold sores are quite common, and many people have a cold sore outbreak a few times a year. Itchy, painful, irritated, and sensitive cold sores are caused by the herpes simplex virus type 1 (HSV-1) and, less commonly, HSV 2. According to the World Health Organization, an estimated 3.7 billion people globally have an HSV-1 infection at a given time, which is the main cause of cold sores. Most cold sores go away within a few weeks without treatment. However, multiple over-the-counter (OTC) ways to treat cold sores can help speed healing without needing to see a healthcare provider. Many people use oral treatments for prevention or treatment, explains Allison K. Truong, MD, a board-certified dermatologist in Beverly Hills, CA. These can reduce symptoms to seven days or prevent the cold sore from forming if you catch it early enough. We surveyed 28 participants to find out which OTC cold sore treatment they tried, how effective it was, and why they liked it. The below over-the-c...
Read more